Not independent
Tenure on this board
9.3 yrs
Meeting calendar
SEER · Annual meeting · Monday, July 7, 2025Contested
Seer Inc
7 nominees · 2 ballot items · contested.
Two proposals are being voted on at the 2025 Seer, Inc. annual meeting: (1) Election of six directors to serve until the 2026 annual meeting, and (2) Ratification of Deloitte & Touche LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2025.
Market cap
$90M
1Y TSR
-16.1%
Board grade
C-
Record date
May 16, 2025
Filing
DEF 14A
Meeting concluded · Jul 7, 2025
Follow how the vote landed and what changed on Seer Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot2
- 1
Election of Directors
ManagementBoard: FORElection of six director nominees to serve until the 2026 annual meeting.
- 2
Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm
ManagementBoard: FORRatify Deloitte & Touche LLP as the independent registered public accounting firm for our fiscal year ending December 31, 2025.
Director elections
Nominees on the ballot7
Independent
Tenure on this board
4.6 yrs
Independent
Tenure on this board
7.4 yrs
Also a director at
Scholar Rock Holding Corp (SRRK)Kalaris Therapeutics Inc (KLRS)
Independent
Tenure on this board
8.6 yrs
Also a director at
Invivyd Inc (IVVD)
Independent
Tenure on this board
8.6 yrs
Independent
Tenure on this board
5.4 yrs
Independent
Tenure on this board
1.9 yrs
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | SOFTBANK GROUP CORP. | 9.3% | 5,135,383 | $9M |
| 2 | Siren, L.L.C. | 4.5% | 2,458,673 | $4M |
| 3 | ACADIAN ASSET MANAGEMENT LLC | 3.8% | 2,074,709 | $3M |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 3.6% | 1,958,996 | $3M |
| 5 | BlackRock, Inc. | 1.9% | 1,035,482 | $2M |
| 6 | RENAISSANCE TECHNOLOGIES LLC | 1.8% | 976,688 | $2M |
| 7 | NANO CAP NEW MILLENNIUM GROWTH FUND L P | 1.5% | 825,000 | $1M |
| 8 | AJU IB Investment Co., Ltd. | 1.5% | 816,375 | $2M |
| 9 | TWO SIGMA INVESTMENTS, LP | 0.9% | 511,598 | $859K |
| 10 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.8% | 459,443 | $772K |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Seer Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Trubridge IncTBRG
Special meeting·Jul 7, 2026·$393M
Cross Country Healthcare IncCCRN
Special meeting·Jul 16, 2026·$427M
Xoma Royalty CorpXOMA
Annual meeting·Jul 13, 2026·$533M
Achieve Life Sciences IncACHV
Annual meeting·Jul 2, 2026·$670M
Aura Biosciences IncAURA
Special meeting·Aug 5, 2026·$734M
Esperion Therapeutics IncESPR
Special meeting·Jul 8, 2026·$814M
Reference
Frequently asked questions
- When is the Seer Inc 2025 annual meeting?
- Seer Inc (SEER) holds its 2025 annual shareholder meeting on Monday, July 7, 2025.
- What is the record date for the Seer Inc 2025 meeting?
- The record date for the Seer Inc 2025 meeting is Friday, May 16, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Seer Inc's 2025 meeting?
- The board is presenting 7 director nominees at the Seer Inc 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Seer Inc 2025 meeting?
- Shareholders will vote on 2 proposals at the Seer Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.